Prolonged survival in a patient with disseminated malignant teratoma in the presence of a persistently elevated serum alpha-fetoprotein level.
The authors report a patient with disseminated malignant teratoma who has survived for 3.5 years after discontinuation of treatment despite a persistent and nonprogressive elevation of his serum alpha-fetoprotein level. Potential sources of the marker in his case are discussed and the possibility of a chemotherapeutically induced evolution of his tumor considered.
Lawson
C S
CS
Department of Medicine, Royal Marsden Hospital, London, England.
Mansi
J L
JL
Wiltshaw
E
E
D000328:Adult; D006801:Humans; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D012186:Retroperitoneal Neoplasms / Q000097:blood; D013724:Teratoma / Q000097:blood* / Q000556:secondary; D000509:alpha-Fetoproteins / Q000378:metabolism*
D000509:alpha-Fetoproteins